Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBDD CBD OF DENVER, INC. (CBDD) Announces the Largest Transaction in Company History https://www.otcmarkets.com/stock/CBDD/news/story?e&id=1643052
$CBDD CBD OF DENVER, INC. (CBDD) Announces the Largest Transaction in Company History https://www.otcmarkets.com/stock/CBDD/news/story?e&id=1643052
Let's see today
I am talking about it
Can't wait for next bounce
Yes they will all chase it soon
USA Equities Corp received IRB Approval for its Novel Allergy Patient Education app study to combat the allergy suffering misery of millions of Americans, especially during allergy seasons.
USA Equities Corp. focuses on healthcare, informatics, and algorithmic personalized medicine. The company intends to develop digital therapeutics, behavior based remote patient monitoring, chronic care, and preventive medicine.
And very thin all the way to 1.00+
Very low float
Need to close the week above 0.02
Reports Indicate Psychedelic Medicine Could be Better Investing Opportunity Than Cannabis
Schmitt told INN he expects to see a continued rush of new listings bring investors opportunities. There has already been an uptick in psychedelics stocks available across the Canadian markets.
The NEO has been heavily involved in the advancement of psychedelics stocks as the exchange includes one of the biggest names in the nascent industry: Mind Medicine (MindMed) (NEO:MMED).
The psychedelics drug development firm went public back in March with the backing of noteworthy investors Bruce Linton and Kevin O’Leary.
Schmitt is hopeful about the sector because of the medical promise attached to research on psychedelic drug compounds. These elements are being investigated in the treatment of serious mental conditions such as post-traumatic stress disorder.
Jos Schmitt of the NEO Exchange is all in on the medical benefits of psychedelic drugs.
“We need to get over that stigma,” said Schmitt, who is president and CEO of the NEO, about the initial doubts that psychedelics as an investment proposition will face.
In an exclusive interview with the Investing News Network (INN), the executive spoke at length about the potential of psychedelics and why the opportunity should entice investors.
INN caught up with Jos Schmitt of the NEO Exchange to learn about the up-and-coming psychedelics investment opportunity.
break 0.035 we good to go
Yep exactly
Yes more companies, more news covering the psychedelic industry
Yes a few traders talking about this stock
I got the word out yesterday let's see if can get more eyes on $PSYC
Yes they are not even buying neither holding so it's just hate
Company latest news: https://www.otcmarkets.com/stock/PSYC/news
Company security details: https://www.otcmarkets.com/stock/PSYC/security
Company profile: https://www.otcmarkets.com/stock/PSYC/profile
Lot of coverage out there, psychedelic is the next cannabis
That's why you don't get married to penny stocks
Buy LOW Sell HIGH
Just swing it
$PSRU Xavier Mitchell, CEO of Valiant Eagle Inc. (PSRU), Releases a Shareholder Letter https://www.otcmarkets.com/stock/PSRU/news/story?e&id=1641634
$PSRU 0.042 x 0.045
If you don't like it don't buy it
Well short term it'll keep bouncing
$ALST O/S 3,936,074 08/04/2020
$ALST O/S 3,936,074 08/04/2020
$PSRU Valiant Eagle Inc. will utilize Kia Kamran P.C.'s services for the acquisition of a sports league that will be announced in the near future. The league has the potential to rival that of the NBA.
$PSRU Valiant Eagle Inc. (OTC:PSRU) is pleased to announce that, with respect to its upcoming acquisition, it has retained the services of Kia Kamran of Kia Kamran P.C. Trademark associate Desiree Torres will also assist in the transaction.
$LEAS accumulation continue!
0.0115 ask again